Introduction Antiphospholipid syndrome (APS) is an autoimmune disease characterised by obstetric morbidity and recurrent ...
Morning Overview on MSN
CAR-T therapy sends 3 autoimmune diseases into remission in 1 patient
A woman in her thirties who was dependent on blood transfusions and unresponsive to every standard treatment for her three ...
Patients with thrombotic antiphospholipid syndrome are better treated with a vitamin K antagonist, such as warfarin, rather than a direct oral anticoagulant (DOAC), a new systematic review and ...
Most clots seen in the antiphospholipid syndrome (APS) are venous; however, a proportion of clots can be arterial, leading to significant morbidity and mortality. Furthermore, arterial vascular ...
Antiphospholipid syndrome (APS) is an autoimmune disorder characterised by the persistent presence of antiphospholipid antibodies (aPL), which significantly increase the risk of thrombosis and adverse ...
Targeting glycolysis can help lower neutrophil extracellular trap formation in antiphospholipid syndrome. Neutrophils are an important type of white blood cell that help your immune system fight ...
Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Preventing the first thrombosis, and better circumvention of the second, are currently the biggest ...
Investigators from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) presented new research findings in antiphospholipid syndrome (APS) at the ...
Antiphospholipid syndrome, also known as APS, is an autoimmune disease that sits at the intersection of inflammation and blood clotting. Antiphospholipid syndrome is best known for increasing the risk ...
Some people with lupus will develop a condition called Antiphospholipid Syndrome (APS). APS can lead to blood clots, and for pregnant women with lupus, pregnancy complications. We talk with Dr. Jane ...
Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Primary prevention remains the biggest treatment challenge in antiphospholipid syndrome, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results